Haleos Labs Limi's revenue decreased 15.6% YoY
  • 30 May 2026
  • Haleos Labs Limited reported a 18.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 15.6%.
  • Its expenses for the quarter were down by 11.5% QoQ and 12.9% YoY.
  • The net profit decreased 94.7% QoQ and decreased 89.9% YoY.
  • The earnings per share (EPS) of Haleos Labs Limited stood at 1.44 during Q4 FY 2025-26.

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Haleos Labs Limited is a company whose primary industry and specific products or services are not provided in the available data. Consequently, detailed information about its market position, industry trends, and any recent major developments is not available. Without additional context, it is not possible to identify any specific strategic initiatives or business focuses that Haleos Labs Limited may have undertaken in the recent past.

In the fourth quarter of FY26, Haleos Labs Limited reported a total income of ₹77.15 crores. This represents a quarter-over-quarter (QoQ) decrease of 18.8% from ₹94.97 crores in Q3FY26. When compared to the same quarter of the previous fiscal year, Q4FY25, where total income was ₹91.45 crores, there is a year-over-year (YoY) reduction of 15.6%. This data indicates a downward trend in revenue performance over both the quarterly and annual periods.

The company's profit before tax (PBT) for Q4FY26 was ₹0.91 crores, showing a significant decrease of 89.6% QoQ from ₹8.78 crores in Q3FY26. Year-over-year, PBT fell by 76.8% from ₹3.93 crores in Q4FY25. The profit after tax (PAT) for Q4FY26 stood at ₹0.35 crores, which is a 94.7% decline QoQ from ₹6.65 crores in Q3FY26 and an 89.9% decrease YoY from ₹3.48 crores in Q4FY25. Earnings per share (EPS) also saw a significant drop to ₹1.44 in Q4FY26 from ₹21.89 in Q3FY26, marking a 93.4% reduction QoQ, and an 85.4% decrease from ₹9.83 in Q4FY25 YoY. These figures reflect a substantial contraction in profitability for the period under review.

Total expenses for Haleos Labs Limited in Q4FY26 amounted to ₹76.25 crores, a decrease of 11.5% from the ₹86.18 crores reported in Q3FY26. Compared to Q4FY25, where total expenses were ₹87.52 crores, there is a YoY decrease of 12.9%. The tax expense in Q4FY26 was ₹0.56 crores, a drop of 73.7% from Q3FY26's ₹2.13 crores. However, compared to the tax expense of ₹0.45 crores in Q4FY25, there is a YoY increase of 24.4%. These operating metrics suggest changes in operational expenditure and tax liabilities, which are reflected in the overall financial performance for the quarter.

Haleos Labs Limited announced its Q4 FY 2025-26 results on 30 May, 2026.

Haleos Labs Limited quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.

Key highlights of Haleos Labs Limited Q4 FY 2025-26 results include:

  • Revenue: ₹77.15 crore
  • Net Profit: ₹0.35 crore
  • EBITDA: ₹6.17 crore
  • Year-over-Year Growth: -15.6%
  • Quarter-over-Quarter Growth: -18.8%

Haleos Labs Limited reported a net loss of ₹0.35 crore in Q4 FY 2025-26, reflecting a -89.9% year-over-year growth.

Haleos Labs Limited posted a revenue of ₹77.15 crore in Q4 FY 2025-26.